SCHEMBL1021848

SCHEMBL1021848

Cc1c(C)c(C)c2[nH]nnc2c1C

nearest known ligand 0.31

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
DYRK1A Q13627 1/20 0.31
RXFP1 Q9HBX9 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13928835 0.81 CSNK2A1 (0.33)
SCHEMBL17225980 0.75
SCHEMBL12320456 0.72
SCHEMBL21991713 0.72 CSNK2A1 (0.42) DYRK1A
SCHEMBL27285056 0.70 DYRK1A (0.32) DYRK1A
SCHEMBL17281159 0.69
SCHEMBL8643113 0.69
SCHEMBL22939690 0.61
SCHEMBL27627272 0.60
SCHEMBL416907 0.59

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 25 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11643398-B2 Metallic salt containing anion having heterocyclic aromatic structure, method of preparing the metallic salt, and electrolyte and electrochemical device each including the metallic salt SAMSUNG ELECTRONICS CO., LTD. (KR) 2023-05-09 US disclosed
EP-2121858-B1 AQUEOUS COATING COMPOSITION HAVING REDUCED PLATE OUT ARKEMA INC (US) 2013-10-16 EP disclosed
CN-101617012-B Aqueous coating composition having reduced plate out ARKEMA 2013-08-28 CN disclosed
US-8450401-B2 Aqueous coating composition having reduced plate out ARKEMA INC. (US) 2013-05-28 US disclosed
US-8450402-B2 Method for reducing plate out of aqueous coating compositions ARKEMA INC. (US) 2013-05-28 US disclosed
US-20120289571-A1 POLYMERIC CONJUGATES OF AROMATIC AMINE CONTAINING COMPOUNDS INCLUDING RELEASABLE UREA LINKER ENZON PHARMACEUTICALS, INC. (US) 2012-11-15 US disclosed
US-20120289571-A1 POLYMERIC CONJUGATES OF AROMATIC AMINE CONTAINING COMPOUNDS INCLUDING RELEASABLE UREA LINKER ENZON PHARMACEUTICALS, INC. (US) 2012-11-15 US disclosed
WO-2011082368-A2 POLYMERIC CONJUGATES OF AROMATIC AMINE CONTAINING COMPOUNDS INCLUDING RELEASABLE UREA LINKER ENZON PHARMACEUTICALS, INC (US) 2011-07-07 WO disclosed
EP-2121824-B8 METHOD FOR REDUCING PLATE OUT OF AQUEOUS COATING COMPOSITIONS ARKEMA INC (US) 2011-02-23 EP disclosed
EP-2121824-B1 METHOD FOR REDUCING PLATE OUT OF AQUEOUS COATING COMPOSITIONS ARKEMA INC (US) 2011-01-12 EP disclosed
EP-2121858-A2 AQUEOUS COATING COMPOSITION HAVING REDUCED PLATE OUT DOW GLOBAL TECHNOLOGIES INC. (US) 2009-11-25 EP disclosed
US-20090087989-A1 POLISHING LIQUID AND POLISHING METHOD USING THE SAME FUJIFILM CORPORATION (JP) 2009-04-02 US disclosed
US-20090087989-A1 POLISHING LIQUID AND POLISHING METHOD USING THE SAME FUJIFILM CORPORATION (JP) 2009-04-02 US disclosed
WO-2008100608-A2 AQUEOUS COATING COMPOSITION HAVING REDUCED PLATE OUT DOW GLOBAL TECHNOLOGIES, INC (US) 2008-08-21 WO disclosed
WO-2008100607-A2 METHOD FOR REDUCING PLATE OUT OF AQUEOUS COATING COMPOSITIONS DOW GLOBAL TECHNOLOGIES, INC (US) 2008-08-21 WO disclosed
US-7393953-B2 Polymeric acyl derivatives of indoles ENZON, INC. (US) 2008-07-01 US disclosed
US-7393953-B2 Polymeric acyl derivatives of indoles ENZON, INC. (US) 2008-07-01 US disclosed
CN-1238561-C Halogen resistant corrosion inhibitors BETZDEARBORN INC (US) 2006-01-25 CN disclosed
US-6464901-B1 IN AQUEOUS SYSTEMS BEING TREATED WITH A HALOGEN BIOCIDE; NONHALOGENATED, NITROGEN CONTAINING, AROMATIC COMPOUNDS; PROVIDING SUBSTITUTION FOR THE HYDROGENS OF THE BENZENE RING OF A BENZOTRIAZOLE BL TECHNOLOGIES, INC. 2002-10-15 US disclosed
CN-1347465-A Halogen resistant corrosion inhibitors BETZDEARBORN INC (US) 2002-05-01 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11643398-B2 Metallic salt containing anion having heterocyclic aromatic structure, method of preparing the metallic salt, and electrolyte and electrochemical device each including the metallic salt NAP1L1, AGTR1, AP2A1 DYRK1A 3862/4885RXFP1 1420/4885
US-20120289571-A1 POLYMERIC CONJUGATES OF AROMATIC AMINE CONTAINING COMPOUNDS INCLUDING RELEASABLE UREA LINKER AURKA, DSTYK, TYR DYRK1A 154/4885RXFP1 2036/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.